Holen Sie sich die Stockscreener-App
12.29
6.61%
-0.87
Handel nachbörslich:
12.30
0.01
+0.08%
Schlusskurs vom Vortag:
$13.16
Offen:
$13.24
24-Stunden-Volumen:
778.49K
Relative Volume:
1.63
Marktkapitalisierung:
$1.14B
Einnahmen:
Nettoeinkommen (Verlust:
$-56.88M
KGV:
-18.61
EPS:
-0.6604
Netto-Cashflow:
$-39.43M
1W Leistung:
-14.71%
1M Leistung:
-18.28%
6M Leistung:
+54.20%
1J Leistung:
+215.94%
1-Tages-Spanne:
$11.99
$13.30
1-Wochen-Bereich:
$11.99
$14.44
52-Wochen-Spanne:
$3.43
$15.79
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Firmenname
Alpha Tau Medical Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare DRTS vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DRTS
Alpha Tau Medical Ltd
|
12.29 | 1.14B | 0 | -56.88M | -39.43M | -0.6604 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-05-28 | Eingeleitet | Barclays | Overweight |
| 2026-03-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-15 | Eingeleitet | Citigroup | Buy |
| 2023-04-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-04-08 | Eingeleitet | Piper Sandler | Overweight |
| 2022-04-04 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Alpha Tau Medical Ltd Aktie (DRTS) Neueste Nachrichten
DRTS 6-K & SEC Filings - Yahoo! Finance Canada
Oramed Pharmaceuticals: Hold Reiterated As Alpha Tau Investment Delivers And More (ORMP) - Seeking Alpha
Is Trial Enrollment Completion Altering The Investment Case For Alpha Tau Medical (DRTS)? - simplywall.st
Is Trial Enrollment Completion Altering The Investment Case For Alpha Tau Medical (DRTS)? - simplywall.st
Alpha Tau Medical (NasdaqCM:DRTS) Stock Forecast & Analyst Predictions - Simply Wall Street
Alpha Tau Medical stock hits 52-week high at 15.11 USD By Investing.com - Investing.com Australia
Is IMPACT Pilot Enrollment Completion Reshaping The Investment Case For Alpha Tau Medical (DRTS)? - simplywall.st
Alpha Tau Medical stock hits 52-week high at 15.11 USD - Investing.com
Alpha Tau Medical stock hits 52-week high at 15.11 USD - Investing.com Canada
Alpha Tau Medical stock hits 52-week high at 15.11 USD - Investing.com Nigeria
Alpha Tau Medical stock hits 52-week high at 15.11 USD - Investing.com India
Alpha Tau Medical stock hits 52-week high at 15.11 USD - Investing.com UK
Alpha Tau: Approaching Massive Year-End; Pounding The Table On Potential GBM Breakthrough - Seeking Alpha
Alpha Tau Medical stock hits 52-week high at 15.11 USD By Investing.com - Investing.com South Africa
Alpha Tau to Participate in September Investor Conferences - Alpha Tau Medical
Alpha Tau to Participate in September Investor Conferences - The Manila Times
Alpha Tau to Participate in September Investor Conferences - Yahoo Finance
H.C. Wainwright reiterates Alpha Tau Medical stock rating on trial enrollment By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Alpha Tau Medical stock rating on trial enrollment - Investing.com Nigeria
H.C. Wainwright reiterates Alpha Tau Medical stock rating on trial enrollment - Investing.com
Alpha Tau Medical (DRTS) finishes pancreatic IMPACT study signup - Stock Titan
Alpha Tau’s pancreatic cancer study grows from 12 to 48 patients as enrollment closes - Stock Titan
Alpha Tau Medical Ltd. Warrant (DRTSW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Alpha Tau Medical Ltd. Warrant (DRTSW) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
Alpha Tau Medical Warrant (DRTSW) Rises 4.1% to $4.05 as Support HoldsStock Picks - careplusvn.com
Enlight (ENLT) Quarterly Results: The Company Releases Its Current Earnings Data in Latest Trading; Post-Report: Shares Move 0.41% Higher on the DayEarnings Stability Report - careplusvn.com
Alpha (DRTS) Quarterly Figures: EPS Falls Short of Its Estimate in the Current Update; Stock Move: Shares Finish 1.27% Down in the Available RecordGeographic Revenue Trends - dars.gov.et
Alpha Tau Medical (DRTS) officer schedules next stock sale under 10b5-1 plan - Stock Titan
Alpha Tau Medical (NASDAQ:DRTS) Sets New 1-Year HighHere's What Happened - MarketBeat
Alpha Tau Medical stock hits 52-week high at 14.79 USD - Investing.com
Alpha Tau Medical stock hits 52-week high at 14.79 USD - Investing.com Canada
Alpha Tau’s Clinical Momentum Put Its Cancer Tech On The Map - Finimize
Price to sales forward of Alpha Tau Medical Ltd. – NASDAQ:DRTSW - TradingView
Price to earnings forward of Alpha Tau Medical Ltd. – NASDAQ:DRTSW - TradingView
Alpha (DRTS) Quarter in Focus: EPS Does Not Reach the Reported Estimate; Share Response - careplusvn.com
Alpha (DRTS) Quarter in Focus: EPS Does Not Reach the Reported Estimate; Share Response - dars.gov.et
Alpha (DRTS) Quarter in Focus: EPS Does Not Reach the Reported Estimate; Share Response: Shares Finish 0.35% Lower for the Current SessionEarnings Miss Alert - dars.gov.et
Alpha (DRTS) Quarter in Focus: EPS Does Not Reach the Reported Estimate; Share Response - dars.gov.et
Price to earnings forward of Alpha Tau Medical Ltd. – BOATS:DRTSW - TradingView
Is Alpha Tau Medical’s (DRTS) Steepening Loss Curve Reframing Its High-Risk Innovation Strategy? - simplywall.st
Is Alpha Tau Medical’s (DRTS) Steepening Loss Curve Reframing Its High-Risk Innovation Strategy? - simplywall.st
Alpha Tau Medical Ltd.: Fundamental Analysis and Financial Ratings | DRTS | IL0011839383 - marketscreener.com
Alpha Tau Medical (XTAE:DRTS) Cyclically Adjusted Price-to-FCF : (As of Aug. 15, 2026) - GuruFocus
Alpha Tau Medical (XTAE:DRTS) Shiller PE Ratio : (As of Aug. 21, 2026) - GuruFocus
DRTS Forecast — Price Target — Prediction for 2027 - TradingView
Q3 EPS Estimate for Alpha Tau Medical Decreased by Analyst - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) Stock Price Down 5.4% Following Insider Selling - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) CFO Sells $248,220.00 in Stock - MarketBeat
H.C. Wainwright raises Alpha Tau Medical stock price target to $16 - Investing.com
H.C. Wainwright raises Alpha Tau Medical stock price target to $16 - Investing.com Nigeria
Finanzdaten der Alpha Tau Medical Ltd-Aktie (DRTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Alpha Tau Medical Ltd-Aktie (DRTS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Levy Raphi | Chief Financial Officer |
Aug 21 '26 |
Sale |
15.00 |
2,871 |
43,073 |
90,180 |
| Raphael (Raphi) Aryeh Levy | Officer |
Aug 21 '26 |
Proposed Sale |
14.36 |
5,000 |
71,800 |
0 |
| Levy Raphi | Chief Financial Officer |
Aug 11 '26 |
Option Exercise |
2.98 |
17,730 |
52,835 |
107,910 |
| Levy Raphi | Chief Financial Officer |
Aug 11 '26 |
Sale |
14.00 |
17,730 |
248,277 |
90,180 |
| Levy Raphi | Chief Financial Officer |
Jul 06 '26 |
Option Exercise |
2.98 |
2,270 |
6,765 |
92,450 |
| Levy Raphi | Chief Financial Officer |
Jul 06 '26 |
Sale |
14.00 |
2,270 |
31,782 |
90,180 |
| Levy Raphi | Officer |
Jul 06 '26 |
Proposed Sale |
13.23 |
20,000 |
264,600 |
0 |
| Levy Raphi | Chief Financial Officer |
Jul 02 '26 |
Option Exercise |
2.98 |
17,873 |
53,262 |
108,053 |
| Levy Raphi | Chief Financial Officer |
Jul 02 '26 |
Sale |
13.00 |
17,873 |
232,397 |
90,180 |
| Levy Raphi | Chief Financial Officer |
Jul 01 '26 |
Option Exercise |
2.98 |
2,127 |
6,338 |
92,307 |
1.60%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):